Lung Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People aged 18 or older, of any gender.
- People who have been diagnosed with peripheral lung cancer (cancer located in the outer areas of the lung), where the largest tumor is no bigger than 3 cm across and there are no more than 3 tumors in total.
- People whose tumor has been assessed by doctors as suitable for a bronchoscopy-guided cryoablation procedure (a freezing treatment reached through a tube passed into the airways).
- People who have refused radiotherapy or chemotherapy, been assessed as unsuitable for those treatments, had no response to previous radiotherapy or chemotherapy, or whose disease has continued to progress after receiving those treatments.
- People who have been assessed as not suitable for surgery, or who have refused surgery and radiotherapy, and who agree to receive the ablation treatment as their first treatment and have signed the required consent form.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have widespread lesions throughout both lungs where ablation treatment would not be expected to improve their condition.
- People whose tests in the month before the procedure show that cancer has spread to lymph nodes near the lung or to areas outside the lung (unless that spread outside the lung has already been controlled by local treatment).
- People who have medical reasons why a bronchoscopy cannot be safely performed, or who are unable to tolerate or cooperate with the procedure.
- People with serious bleeding tendencies or blood clotting problems that cannot be corrected (confirm with trial site for specific blood test values).
- People with a low platelet count (a blood cell important for clotting) below a certain level, or who have stopped taking blood-thinning or anti-clotting medications less than one week before the procedure (with an exception for a specific type of low-dose blood thinner used before the operation — confirm with trial site).
- People with severely reduced lung function, where the maximum amount of air they can breathe in and out is below 40% of the expected level.
- People who also have another cancer with widespread spread throughout the body and whose expected survival is less than 3 months.
- People in poor overall health, including those with widespread spread throughout the body, severe infection, high fever, significant muscle and weight loss, severe organ problems, severe anaemia, or serious nutritional or metabolic problems that cannot be corrected in the short term, as well as those with infection or radiation-related inflammation around the tumor area.
- People with an ECOG performance status score above 2 — this is a standard medical rating scale for how much a person's illness affects their daily activities (confirm with trial site).
- People whose tumor to be treated has received radiotherapy within the past 6 months.
- People with active hepatitis B, active hepatitis C, a known HIV infection, or other active infections that the treating doctor judges could affect the person's treatment.
- People who have epilepsy, a history of mental illness, or cognitive impairment (problems with thinking or memory).
- Women who are pregnant or breastfeeding, as well as any person (male or female) who plans to have children or become pregnant during the trial.
- People who have taken part in any other clinical trial involving an active intervention in the 3 months before signing the consent form.
- People who the treating doctor considers unsuitable for the trial for any other reason.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 020-81566640
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.
Primary endpoints
Complete Ablation Rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.